Abstract
TReatment for ImmUne Mediated PathopHysiology (TRIUMPH) is a multi-center, three arm,
randomized, controlled trial of immunosuppressive therapy for children with acute liver
failure. The study will determine if suppressing inflammatory responses with either
corticosteroids or equine anti-thymocyte globulin therapy improves survival for children with
this rare, life-threatening condition.
